Novozymes A/S banner

Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93% Market Closed
Market Cap: kr165.6B

Gross Margin

54.3%
Current
Improving
by 0.1%
vs 3-y average of 54.2%

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
54.3%
=
Gross Profit
kr9.7B
/
Revenue
kr17.9B

Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.

Gross Margin
54.3%
=
Gross Profit
kr9.7B
/
Revenue
kr17.9B

Peer Comparison

Country Company Market Cap Gross
Margin
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK
Loading...
US
Sherwin-Williams Co
NYSE:SHW
81.3B USD
Loading...
US
Ecolab Inc
NYSE:ECL
79.6B USD
Loading...
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
11.7T JPY
Loading...
JP
Yasuhara Chemical Co Ltd
TSE:4957
10.8T JPY
Loading...
CN
Wanhua Chemical Group Co Ltd
SSE:600309
291.6B CNY
Loading...
CH
Givaudan SA
SIX:GIVN
26.5B CHF
Loading...
US
PPG Industries Inc
NYSE:PPG
24.1B USD
Loading...
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.2T INR
Loading...
CH
Sika AG
F:SIKA
19.9B EUR
Loading...
US
Albemarle Corp
NYSE:ALB
19.1B USD
Loading...

Market Distribution

In line with most companies in Denmark
Percentile
55th
Based on 447 companies
55th percentile
54.3%
Low
-2 199.8% — 26.7%
Typical Range
26.7% — 65.9%
High
65.9% — 1 637.7%
Distribution Statistics
Denmark
Min -2 199.8%
30th Percentile 26.7%
Median 45.7%
70th Percentile 65.9%
Max 1 637.7%

Novozymes A/S
Glance View

Market Cap
165.6B DKK
Industry
Chemicals

Novozymes A/S, a beacon of innovation in biotechnology, operates at the intricate intersection of science and sustainability. Born from the storied roots of Novo Nordisk in 2000, this Danish company has carved out a niche in the enzyme and microbial sector. Novozymes’ core competency lies in its ability to harness the power of natural organisms, using them to drive forward industrial solutions that are not only efficient but also eco-friendly. The company’s extensive portfolio of enzymes transforms processes across a diverse array of industries, including agriculture, food and beverages, household care, and bioenergy. By engineering microorganisms to optimize yield and reduce waste, Novozymes provides solutions that both enhance product performance and support environmental goals. Revenue generation for Novozymes predominantly stems from its ability to innovate and provide proprietary solutions that businesses around the world rely on to gain a competitive edge. While enzymes in detergents simplify stain removal and enable energy-efficient washing at lower temperatures, in agriculture, Novozymes' biological solutions enhance crop yield by fostering nutrient absorption and pest resilience. This vast spectrum of applications showcases the company's deep integration into its clients' production processes, creating a stable demand. Novozymes capitalizes on its research and development prowess, ensuring a continuous flow of advanced, tailor-made bio-solutions, thereby securing long-term partnerships and a sustainable revenue stream from its global market presence.

NZYM B Intrinsic Value
Not Available
What is Gross Margin?
Gross Margin shows how much money a company keeps from each dollar of sales after paying for the products it sells. It tells how profitable the company`s core business is before other expenses.
How is Gross Margin calculated?

Gross Margin is calculated by dividing the Gross Profit by the Revenue.

Gross Margin
54.3%
=
Gross Profit
kr9.7B
/
Revenue
kr17.9B
What is Novozymes A/S's current Gross Margin?

The current Gross Margin for Novozymes A/S is 54.3%, which is above its 3-year median of 54.2%.

How has Gross Margin changed over time?

Over the last 3 years, Novozymes A/S’s Gross Margin has decreased from 56% to 54.3%. During this period, it reached a low of 54.2% on Jun 30, 2023 and a high of 57.8% on Dec 31, 2021.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett